Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease

Patients with chronic inflammatory diseases (CID) experience accelerated loss of bone mineral density, which is often accompanied by increased vascular calcification. These disturbances can be attenuated by therapies for inflammation, such as the tumor necrosis factor inhibitor infliximab. Calciprot...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JBMR Plus
Egile Nagusiak: Tiong, Mark K, Smith, Edward R, Toussaint, Nigel D, Al‐Khayyat, Hasan F, Holt, Stephen G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Inc. 2021
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216135/
https://ncbi.nlm.nih.gov/pubmed/34189386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10497
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak